A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure. (NCT07222917)

🧪 Interventions in This Study

• Baxdrostat/dapagliflozin (DRUG)
• Baxdrostat/Placebo (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (71 Sites)

Showing the first 25 of 71 sites.

• Research Site — Surprise, Arizona
• Research Site — Hollywood, Florida
• Research Site — Port Charlotte, Florida
• Research Site — Port Orange, Florida
• Research Site — Atlanta, Georgia
• Research Site — Champaign, Illinois
• Research Site — Wichita, Kansas
• Research Site — Eatontown, New Jersey
• Research Site — Greenville, North Carolina
• Research Site — Jacksonville, North Carolina
• Research Site — New Bern, North Carolina
• Research Site — Columbus, Ohio
• Research Site — Media, Pennsylvania
• Research Site — East Providence, Rhode Island
• Research Site — Arlington, Texas
• Research Site — Pasadena, Texas
• Research Site — San Antonio, Texas
• Research Site — Woodbridge, Virginia
• Research Site — Buenos Aires,
• Research Site — Ciudad de Buenos Aires,
• Research Site — Mar del Plata,
• Research Site — Rosario,
• Research Site — San Nicolás,
• Research Site — Pernik,
• Research Site — Plovdiv,

📞 Contact the Study Coordinator

Phone: (877) 240-9479

Email: information.center@astrazeneca.com

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Chronic Kidney Disease and Hypertension

• A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure. — Fairhope, Alabama
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure — Fairhope, Alabama

Explore by condition: All Chronic Kidney Disease and Hypertension clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.